119 related articles for article (PubMed ID: 38160013)
1. Peptide L13S Derived from the BRN2 POU Domain Reduces Metastasis
Cesar MCM; Mortara RA; Souza VS; Alves VRG; Paschoalin T; Soufen MA; DE Freitas GM; DA Cunha FFM; Tada DB; Dobroff AS; Arruda DC
Anticancer Res; 2024 Jan; 44(1):71-84. PubMed ID: 38160013
[TBL] [Abstract][Full Text] [Related]
2. Peptide R18H from BRN2 Transcription Factor POU Domain Displays Antitumor Activity In Vitro and In Vivo and Induces Apoptosis in B16F10-Nex2 Cells.
da Cunha FFM; Mugnol KCU; de Melo FM; Nascimento MVSQ; de Azevedo RA; Santos RTS; Magalhães JA; Miguel DC; Tada DB; Mortara RA; Travassos LR; Arruda DC
Anticancer Agents Med Chem; 2019; 19(3):389-401. PubMed ID: 30417795
[TBL] [Abstract][Full Text] [Related]
3. MITF and BRN2 contribute to metastatic growth after dissemination of melanoma.
Simmons JL; Pierce CJ; Al-Ejeh F; Boyle GM
Sci Rep; 2017 Sep; 7(1):10909. PubMed ID: 28883623
[TBL] [Abstract][Full Text] [Related]
4. Prosopis juliflora (Sw.) DC phytochemicals induce apoptosis and inhibit cell proliferation signaling pathways, EMT, migration, invasion, angiogenesis and stem cell markers in melanoma cell lines.
Choudhari J; Nimma R; Nimal SK; Totakura Venkata SK; Kundu GC; Gacche RN
J Ethnopharmacol; 2023 Aug; 312():116472. PubMed ID: 37062530
[TBL] [Abstract][Full Text] [Related]
5. BRN2, a POUerful driver of melanoma phenotype switching and metastasis.
Fane ME; Chhabra Y; Smith AG; Sturm RA
Pigment Cell Melanoma Res; 2019 Jan; 32(1):9-24. PubMed ID: 29781575
[TBL] [Abstract][Full Text] [Related]
6. NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF.
Fane ME; Chhabra Y; Hollingsworth DEJ; Simmons JL; Spoerri L; Oh TG; Chauhan J; Chin T; Harris L; Harvey TJ; Muscat GEO; Goding CR; Sturm RA; Haass NK; Boyle GM; Piper M; Smith AG
EBioMedicine; 2017 Feb; 16():63-75. PubMed ID: 28119061
[TBL] [Abstract][Full Text] [Related]
7. Phenethyl Isothiocyanate (PEITC) and Benzyl Isothiocyanate (BITC) Inhibit Human Melanoma A375.S2 Cell Migration and Invasion by Affecting MAPK Signaling Pathway
Ma YS; Hsiao YT; Lin JJ; Liao CL; Lin CC; Chung JG
Anticancer Res; 2017 Nov; 37(11):6223-6234. PubMed ID: 29061805
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal Regulation of BRN2 and NOTCH1/2 Signaling Synergistically Drives Melanoma Cell Migration and Invasion.
Fane ME; Chhabra Y; Spoerri L; Simmons JL; Ludwig R; Bonvin E; Goding CR; Sturm RA; Boyle GM; Haass NK; Piper M; Smith AG
J Invest Dermatol; 2022 Jul; 142(7):1845-1857. PubMed ID: 34958806
[TBL] [Abstract][Full Text] [Related]
9. Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells.
Ragone C; Minopoli M; Ingangi V; Botti G; Fratangelo F; Pessi A; Stoppelli MP; Ascierto PA; Ciliberto G; Motti ML; Carriero MV
J Exp Clin Cancer Res; 2017 Dec; 36(1):180. PubMed ID: 29216889
[TBL] [Abstract][Full Text] [Related]
10. Licochalcone D induces apoptosis and inhibits migration and invasion in human melanoma A375 cells.
Si L; Yan X; Hao W; Ma X; Ren H; Ren B; Li D; Dong Z; Zheng Q
Oncol Rep; 2018 May; 39(5):2160-2170. PubMed ID: 29565458
[TBL] [Abstract][Full Text] [Related]
11. Anti-metastatic Effects of Cationic KT2 Peptide (a Lysine/Tryptophan-rich Peptide) on Human Melanoma A375.S2 Cells.
Maraming P; Klaynongsruang S; Boonsiri P; Peng SF; Daduang S; Rungsa P; Tavichakorntrakool R; Chung JG; Daduang J
In Vivo; 2021; 35(1):215-227. PubMed ID: 33402468
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of BRN2 modulates its interaction with the Pax3 promoter to control melanocyte migration and proliferation.
Berlin I; Denat L; Steunou AL; Puig I; Champeval D; Colombo S; Roberts K; Bonvin E; Bourgeois Y; Davidson I; Delmas V; Nieto L; Goding CR; Larue L
Mol Cell Biol; 2012 Apr; 32(7):1237-47. PubMed ID: 22290434
[TBL] [Abstract][Full Text] [Related]
13. Casticin Inhibits A375.S2 Human Melanoma Cell Migration/Invasion through Downregulating NF-κB and Matrix Metalloproteinase-2 and -1.
Wu ZY; Lien JC; Huang YP; Liao CL; Lin JJ; Fan MJ; Ko YC; Hsiao YP; Lu HF; Chung JG
Molecules; 2016 Mar; 21(3):384. PubMed ID: 27007357
[TBL] [Abstract][Full Text] [Related]
14. Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras.
Lo C; Lai TY; Yang JS; Yang JH; Ma YS; Weng SW; Lin HY; Chen HY; Lin JG; Chung JG
Melanoma Res; 2011 Aug; 21(4):267-73. PubMed ID: 21734530
[TBL] [Abstract][Full Text] [Related]
15. Casticin impairs cell migration and invasion of mouse melanoma B16F10 cells via PI3K/AKT and NF-κB signaling pathways.
Shih YL; Chou HM; Chou HC; Lu HF; Chu YL; Shang HS; Chung JG
Environ Toxicol; 2017 Sep; 32(9):2097-2112. PubMed ID: 28444820
[TBL] [Abstract][Full Text] [Related]
16. A novel microtubule de-stabilizing complementarity-determining region C36L1 peptide displays antitumor activity against melanoma in vitro and in vivo.
Figueiredo CR; Matsuo AL; Azevedo RA; Massaoka MH; Girola N; Polonelli L; Travassos LR
Sci Rep; 2015 Sep; 5():14310. PubMed ID: 26391685
[TBL] [Abstract][Full Text] [Related]
17. Berberine Inhibits Human Melanoma A375.S2 Cell Migration and Invasion via Affecting the FAK, uPA, and NF-κB Signaling Pathways and Inhibits PLX4032 Resistant A375.S2 Cell Migration In Vitro.
Liu JF; Lai KC; Peng SF; Maraming P; Huang YP; Huang AC; Chueh FS; Huang WW; Chung JG
Molecules; 2018 Aug; 23(8):. PubMed ID: 30104528
[TBL] [Abstract][Full Text] [Related]
18. Effects of miR-145-5p through NRAS on the cell proliferation, apoptosis, migration, and invasion in melanoma by inhibiting MAPK and PI3K/AKT pathways.
Liu S; Gao G; Yan D; Chen X; Yao X; Guo S; Li G; Zhao Y
Cancer Med; 2017 Apr; 6(4):819-833. PubMed ID: 28332309
[TBL] [Abstract][Full Text] [Related]
19. Ursolic Acid Exhibits Potent Anticancer Effects in Human Metastatic Melanoma Cancer Cells (SK-MEL-24) via Apoptosis Induction, Inhibition of Cell Migration and Invasion, Cell Cycle Arrest, and Inhibition of Mitogen-Activated Protein Kinase (MAPK)/ERK Signaling Pathway.
Liu P; Du R; Yu X
Med Sci Monit; 2019 Feb; 25():1283-1290. PubMed ID: 30772887
[TBL] [Abstract][Full Text] [Related]
20. Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation.
Zeng H; Jorapur A; Shain AH; Lang UE; Torres R; Zhang Y; McNeal AS; Botton T; Lin J; Donne M; Bastian IN; Yu R; North JP; Pincus L; Ruben BS; Joseph NM; Yeh I; Bastian BC; Judson RL
Cancer Cell; 2018 Jul; 34(1):56-68.e9. PubMed ID: 29990501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
